Vancouver, British Columbia and Rehovot, Israel – September 4, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 – 10, 2024 at the Lotte New […]
Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of at Least $6.5 Million, with a Gross Profit Margin of 52%+ Vancouver, British Columbia and Rehovot, Israel – August 29, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering
BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results Read More »
Vancouver, British Columbia and Rehovot, Israel – August 28 , 2024 – – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA® Superfood Coffee and Decaf Coffee, a “functional” coffee product line integrating flagship nutraceutical product VINIA® Red Grape Superfood
Vancouver, British Columbia and Rehovot, Israel – August 23, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will host a corporate update call on Thursday, August 29, 2024. On the call, CEO Ilan Sobel will discuss commercial progress and
Vancouver, British Columbia and Rehovot, Israel – June 28, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD) has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 share units at USD $7.17 per unit raising a total of USD $4,329,982.62 (approx. CAD $5,926,000).
Vancouver, British Columbia and Rehovot, Israel – June 24, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCD), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024. CEO Ilan Sobel is scheduled to
